Market Overview:
The Global Systemic Infection Therapy Market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing incidence of infectious diseases, rising demand for better treatment options, and technological advancements in systemic infection therapy products. Based on type, the global systemic infection therapy market is segmented into oral, intravenous, and topical segments. The intravenous segment is expected to account for the largest share of the global market in 2018 owing to its high efficacy and growing demand for better treatment options. Based on application, the global systemic infection therapy market is segmented into hospitals, clinics, and others segments. The hospitals segment accounted for a major share of the global market in 2017 due to increasing number of hospital admissions owing to infectious diseases worldwide. Geographically, North America was estimated as having held majority share (around 38%) followed by Europe (27%), Asia Pacific (24%), Latin America (8%), and Middle East & Africa region(4%).
Product Definition:
A systemic infection is an infection that has spread throughout the body. Systemic infection therapy is a treatment approach that uses antibiotics or other medications to treat infections that have spread throughout the body. The use of systemic infection therapy is important because it can help to improve the patient's overall health and may even save their life.
Oral:
Oral is a route of drug administration which involves the use of drugs in pill or liquid form that is administered through the mouth. The oral drug delivery system has been an important part of pharmacy practice for centuries. With technological advancements, it has become easier to develop and administer drugs in this delivery method.
Intravenous:
Intravenous (IV) therapy is a method of delivering medications and fluids directly into the blood vessels. It is used in systemic infection treatment by allowing drugs to reach sites that are inaccessible or difficult to administer parenterally. IV medication administration can be done manually with the help of a machine, which pumps liquid into a patient's veins through tubes or can be automatic in nature where IV solutions are inserted into the patient's vein by means of an infusion pump.
Application Insights:
The hospitals segment dominated the global systemic infection therapy market in 2017. This can be attributed to a large patient base and high prevalence of chronic diseases, such as cancer, respiratory disorders, and diabetes. Moreover, an increase in hospital-acquired infections is expected to drive the demand for SIT over the forecast period. According to a study published by NCBI in 2018; it was found that around 60% of patients acquiring bloodstream infections at hospitals had no identified source of infection. Thus rising cases of hospital acquired infections are expected to contribute towards segment growth during the forecast period.
The others application segment includes clinics and other healthcare facilities such as imaging centers and urgent care centers that provide systemic infection treatment services without being classified as full blown hospitals or medical offices buildings with an isolation unit within them (such health facilities may have their own formularies).
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement scenario, and increasing healthcare expenditure are some of the factors responsible for its dominance. In addition, growing interest among patients in systemic infection therapy and availability of approved products are also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising incidence rates of multi-drug resistant tuberculosis (MDR TB) coupled with increasing awareness about available treatment options & their efficacy. For instance, Moxifloxacin tablets were recently FDA approved by Indian FDA for treating active pulmonary tuberculosis disease in adults & children above 1 year old who have been properly diagnosed by a physician as per guidelines set by WHO & UNICEF (2017). Such initiatives undertaken by manufacturers boost product sales which eventually leads to revenue generation from this region over the next eight years.
Growth Factors:
- Increasing incidence of systemic infections: The global incidence of systemic infections is increasing due to the growing population and the increase in travel and trade. This is driving the demand for systemic infection therapy products.
- Growing awareness about systemic infection therapy: There is a growing awareness about the benefits of systematic infection therapy products among healthcare professionals and patients alike, which is driving market growth.
- Technological advancements in systemic infection therapies: There has been a significant advancement in technology for developing novel therapies for treating system infections, which is propelling market growth.
- Rising demand for combination therapies: The trend towards using combination therapies to treat system infections is gaining traction, owing to their better efficacy than monotherapy regimens. This is fuelling market growth significantly. 5) Expanding product pipeline: A large number of companies are investing in R&D to develop new products with better efficacy and safety profiles, which will help fuel market growth over the forecast period
Scope Of The Report
Report Attributes
Report Details
Report Title
Systemic Infection Therapy Market Research Report
By Type
Oral, Intravenous, Topical
By Application
Hospitals, Clinics, Others
By Companies
Abbott Laboratories, Merck & Co., Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, Sun Pharmaceuticals, Roche, Astra Zeneca, Wockhardt, Mylan Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Systemic Infection Therapy Market Report Segments:
The global Systemic Infection Therapy market is segmented on the basis of:
Types
Oral, Intravenous, Topical
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Merck & Co.
- Pfizer
- GlaxoSmithKline
- Novartis
- Johnson & Johnson
- Sun Pharmaceuticals
- Roche
- Astra Zeneca
- Wockhardt
- Mylan Pharma
Highlights of The Systemic Infection Therapy Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Intravenous
- Topical
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Systemic Infection Therapy Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Systemic infection therapy is a treatment approach that uses antibiotics to treat infections throughout the body. Systemic infection therapy is often used in combination with other treatments, such as surgery or radiation, to help cure the patient's underlying condition.
Some of the major players in the systemic infection therapy market are Abbott Laboratories, Merck & Co., Pfizer, GlaxoSmithKline, Novartis, Johnson & Johnson, Sun Pharmaceuticals, Roche, Astra Zeneca, Wockhardt, Mylan Pharma.
The systemic infection therapy market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Systemic Infection Therapy Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Systemic Infection Therapy Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Systemic Infection Therapy Market - Supply Chain
4.5. Global Systemic Infection Therapy Market Forecast
4.5.1. Systemic Infection Therapy Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Systemic Infection Therapy Market Size (000 Units) and Y-o-Y Growth
4.5.3. Systemic Infection Therapy Market Absolute $ Opportunity
5. Global Systemic Infection Therapy Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Systemic Infection Therapy Market Size and Volume Forecast by Type
5.3.1. Oral
5.3.2. Intravenous
5.3.3. Topical
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Systemic Infection Therapy Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Systemic Infection Therapy Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Systemic Infection Therapy Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Systemic Infection Therapy Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Systemic Infection Therapy Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Systemic Infection Therapy Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Systemic Infection Therapy Demand Share Forecast, 2019-2026
9. North America Systemic Infection Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Systemic Infection Therapy Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Systemic Infection Therapy Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Systemic Infection Therapy Market Size and Volume Forecast by Type
9.7.1. Oral
9.7.2. Intravenous
9.7.3. Topical
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Systemic Infection Therapy Demand Share Forecast, 2019-2026
10. Latin America Systemic Infection Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Systemic Infection Therapy Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Systemic Infection Therapy Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Systemic Infection Therapy Market Size and Volume Forecast by Type
10.7.1. Oral
10.7.2. Intravenous
10.7.3. Topical
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Systemic Infection Therapy Demand Share Forecast, 2019-2026
11. Europe Systemic Infection Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Systemic Infection Therapy Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Systemic Infection Therapy Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Systemic Infection Therapy Market Size and Volume Forecast by Type
11.7.1. Oral
11.7.2. Intravenous
11.7.3. Topical
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y--Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Systemic Infection Therapy Demand Share, 2019-2026
12. Asia Pacific Systemic Infection Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Systemic Infection Therapy Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Systemic Infection Therapy Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Systemic Infection Therapy Market Size and Volume Forecast by Type
12.7.1. Oral
12.7.2. Intravenous
12.7.3. Topical
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Systemic Infection Therapy Demand Share, 2019-2026
13. Middle East & Africa Systemic Infection Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Systemic Infection Therapy Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Systemic Infection Therapy Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Systemic Infection Therapy Market Size and Volume Forecast by Type
13.7.1. Oral
13.7.2. Intravenous
13.7.3. Topical
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Systemic Infection Therapy Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Systemic Infection Therapy Market: Market Share Analysis
14.2. Systemic Infection Therapy Distributors and Customers
14.3. Systemic Infection Therapy Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck & Co.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. GlaxoSmithKline
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson & Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Sun Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Astra Zeneca
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Wockhardt
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Mylan Pharma
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
